NCT00869219
Unknown
Phase 4
Phase 4 Study of Topical NSAID for Ophthalmologic Use: Pain Measurement After First Drop.
Santa Casa de Misericordia de Santos1 site in 1 country40 target enrollmentMarch 2009
Overview
- Phase
- Phase 4
- Intervention
- Nevanac
- Conditions
- Pain
- Sponsor
- Santa Casa de Misericordia de Santos
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Pain after instilation
- Last Updated
- 17 years ago
Overview
Brief Summary
Different case reports are showing that depending on the drug used for eye drops, it might provoke a painful sensation. Actually two leading NSAIDs are used in ophthalmology. This study is intended to provide information about this parameter concerning these two drugs.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient over 21 years old
- •No ocular surface pathology
- •Eligible for cataract surgery
Exclusion Criteria
- •Any other eye pathology other than cataract
Arms & Interventions
Nevanac
Intervention: Nevanac
Acular LS
Intervention: Acular LS
Outcomes
Primary Outcomes
Pain after instilation
Time Frame: 5 min
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 4
Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in PrematurityRetinopathy of PrematurityRetinal DetachmentBlindnessNCT00634972University of South Alabama83
Unknown
Not Applicable
Steroids Versus Non-steroidal Anti-inflammatory Drugs Following Glaucoma SurgeryGlaucomaNCT00956462University Health Network, Toronto36
Completed
Phase 1
New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in CystinosisCystinosisNCT00001736National Eye Institute (NEI)51
Completed
Not Applicable
Influence of therapeutic agent for glaucoma on biological clockJPRN-jRCTs071180026Yoshihara Tatsuya16
Completed
Not Applicable
ILLEffects of using Ocular Medications without prescription.CTRI/2021/04/033162Dr Pinnamaneni Siddartha institute of medical sciences and research foundation100